Seeking Alpha

Seeking Alpha Portfolio App for iPad

James Stocklasar Thomas Jr.

James Stocklasar Thomas Jr. picture

James Stocklasar Thomas Jr.

Profile

Send Message

View as an RSS Feed

View James Stocklasar Thomas Jr.'s Articles BY TICKER:

Savvy Investors Discover Antares' Growing Revenue Stream
on Thu, Jan 17 • ATRS • 15 Comments
The Future Of Zalicus In 2013
on Tue, Jan 15 • ZLCS • 39 Comments
Recalculating Celsion's Upcoming Results
on Mon, Jan 14 • CLSN • 33 Comments
Why Is Antares Rising So Quickly?
on Wed, Jan 9 • ATRS • 34 Comments
Why Growth Stock Antares Is Moving Higher
on Mon, Jan 7 • ATRS • 29 Comments
Celsion: The Heat Is On
on Wed, Jan 2 • ACAD, BPAX, CLSN • 21 Comments
Sizing Up Celsion's Odds Of Success
on Fri, Dec 21, 2012 • ACAD, CLSN • 22 Comments
Why Celsion Is A Strong Buy On The Dip
on Mon, Dec 17, 2012 • CLSN • 23 Comments
Pre-HEAT Celsion Catalysts Confirm Strong Buy
on Fri, Dec 14, 2012 • PHG, CLSN • 9 Comments
A Reasoned Case For Celsion's ThermoDox
on Mon, Dec 10, 2012 • ACAD, VVUS, CLSN • 20 Comments
Cel-Sci: Immunotherapy Opens New Door To Investors
on Thu, Dec 6, 2012 • DNDN, TEVA, CVM • 13 Comments
Buying Teva's Immunotherapy Investment
on Wed, Dec 5, 2012 • TEVA, CVM • 9 Comments
Top 5 Fiscal Cliff Biotech Buys
on Wed, Dec 5, 2012 • AMRN, ARNA, CLSN • 10 Comments
Smart Day Traders Ring The Register On Acadia And Zalicus
on Wed, Nov 28, 2012 • ACAD, CPRX, SNY • 15 Comments
Why Cash Overrules The Momentary Market Bounce
on Tue, Nov 27, 2012 • ACAD, AEZS, ARNA • 14 Comments
Why I'm 'In Cash' For Biotechs In A Bearish Market
on Wed, Nov 21, 2012 • AEZS, ARNA, ASTX • 37 Comments
Acadia's Bubbling To Move Higher
on Thu, Oct 18, 2012 • ACAD • 24 Comments
Why Acadia May Be This Year's Holiday Prize
on Wed, Oct 17, 2012 • CPRX, ACAD • 28 Comments
Time To Buy Housing Stocks Like DR Horton
on Mon, Oct 15, 2012 • DHI • 1 Comment
How Sirius Could Grow Its Bottom Line
on Mon, Oct 15, 2012 • LMCA, SIRI • 33 Comments
BioClinica: A Stealth Stock For Savvy Buyers?
on Wed, Oct 3, 2012 • BIOC • Comment!
Reconsidering Zalicus And Antares In Light Of Shakeups
on Wed, Oct 3, 2012 • ATRS, ACAD, NVS • 18 Comments
A Reasoned Case For Pimavanserin's Success
on Mon, Sep 24, 2012 • ACAD • 10 Comments
Under Construction Rehash: Buy Acadia And Astex
on Thu, Sep 20, 2012 • ACAD, AEZS, ASTX • 24 Comments
More Evidence For Catalyst's Potential Vigabatrin Success
on Mon, Sep 17, 2012 • ASTX, DVAX, ZLCS • 23 Comments
Buying Into Catalyst Pharma's Fast Tracked Vigabatrim On Friday
on Fri, Sep 14, 2012 • ASTX, CPRX • 36 Comments
Zalicus Misses Key Secondary Endpoint
on Mon, Sep 10, 2012 • AMGN, NVS, SNY • 30 Comments
Astex's Linear Rise Versus Peregrine's And Cell Therapeutics' Sudden Pop
on Mon, Sep 10, 2012 • ATRS, CTIC, PPHM • 15 Comments
Bulls Keep Knocking On Astex's Door
on Tue, Sep 4, 2012 • AZN, GSK, JNJ • 12 Comments
Zalicus: When Push Comes To Shove
on Fri, Aug 31, 2012 • ATRS, CBST, COV • 77 Comments
Early Thursday: Make Money On Zalicus, Why Not?
on Thu, Aug 30, 2012 • AMGN, MRK, NVS • 24 Comments
Going Into Monday Zalicus' S-3 Surprise
on Mon, Aug 27, 2012 • AMGN, BPAX, CBST • 30 Comments